122 related articles for article (PubMed ID: 2979847)
1. Tamoxifen tolerance and steroid receptors in a tumor model.
Kellen JA; Sutherland DJ
In Vivo; 1988; 2(3-4):299-300. PubMed ID: 2979847
[TBL] [Abstract][Full Text] [Related]
2. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
[TBL] [Abstract][Full Text] [Related]
3. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
Koenders AJ; Beex LV; Geurts-Moespot J; Benraad TJ
Eur J Cancer (1965); 1980; Suppl 1():63-6. PubMed ID: 7318871
[No Abstract] [Full Text] [Related]
4. A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice.
Simian M; Manzur T; Rodriguez V; de Kier Joffé EB; Klein S
Breast Cancer Res Treat; 2009 Jan; 113(1):1-8. PubMed ID: 18183485
[TBL] [Abstract][Full Text] [Related]
5. Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions.
Pontiggia O; Rodriguez V; Fabris V; Raffo D; Bumaschny V; Fiszman G; de Kier Joffé EB; Simian M
Breast Cancer Res Treat; 2009 Jul; 116(2):247-55. PubMed ID: 18622696
[TBL] [Abstract][Full Text] [Related]
6. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
Ip MM; Milholland RJ; Rosen F; Kim U
Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
[TBL] [Abstract][Full Text] [Related]
7. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
8. Pyrrolidino-4-iodotamoxifen and 4-iodotamoxifen, new analogues of the antiestrogen tamoxifen for the treatment of breast cancer.
Chander SK; McCague R; Luqmani Y; Newton C; Dowsett M; Jarman M; Coombes RC
Cancer Res; 1991 Nov; 51(21):5851-8. PubMed ID: 1933854
[TBL] [Abstract][Full Text] [Related]
9. Decreased P-glycoprotein in a tamoxifen-tolerant breast carcinoma model.
Kellen JA; George E; Ling V
Anticancer Res; 1991; 11(3):1243-4. PubMed ID: 1679618
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of malignant breast tumors containing estrogen receptors].
El'tsina NV
Vopr Onkol; 1982; 28(4):95-102. PubMed ID: 7046238
[No Abstract] [Full Text] [Related]
11. Toremifene resistance in a rat mammary tumour model.
Kellen JA; Georges E; Ling V; Dubsky M
Anticancer Res; 1992; 12(5):1663-5. PubMed ID: 1359832
[TBL] [Abstract][Full Text] [Related]
12. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
Ip MM; Milholland RJ; Rosen F
Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
[TBL] [Abstract][Full Text] [Related]
13. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
Waseda N; Kato Y; Imura H; Kurata M
Cancer Res; 1981 May; 41(5):1984-8. PubMed ID: 7214366
[TBL] [Abstract][Full Text] [Related]
14. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
[TBL] [Abstract][Full Text] [Related]
15. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
16. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
17. Female sex steroid receptors in post menopausal endometrial carcinoma. Biochemical responses to antiestrogen and progestin.
Robel P; Gravanis A; Roger-Jallais L; Catelli MG; Binart N; George M; Laval C; Baulieu EE
Prog Clin Biol Res; 1984; 142():167-79. PubMed ID: 6709656
[No Abstract] [Full Text] [Related]
18. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
19. Steroid receptors in breast tumors--current status.
McGuire WL; Zava DT; Horwitz KB; Chamness GC
Curr Top Exp Endocrinol; 1978; 3():93-129. PubMed ID: 350504
[No Abstract] [Full Text] [Related]
20. Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats.
Inoh A; Kamiya K; Fujii Y; Yokoro K
Jpn J Cancer Res; 1985 Aug; 76(8):699-704. PubMed ID: 3930447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
